Women are almost twice as likely as men to be diagnosed with an autoimmune disease and make up nearly 80% of those affected.
Defying easy description, this little dynamo offers a ton of handy functionality without taking up much space.
TRUTAKNA is the first and only available therapy that binds both B-cell activating factor (BAFF) and A PRoliferation-Inducing Ligand (APRIL), addressing the immunological drivers at the source of IgA ...
Babies born in the U.S. between July 2 and Dec. 31, 2026, will receive a "first-of-its-kind" commemorative Social Security card.
The semiconductor industry remains a critical pillar of technological innovation, powering everything from AI to ...
Over the past decade, red light therapy has moved steadily from clinical settings into mainstream wellness. Once found ...
Recent technological advances have opened valuable possibilities for supporting people with motor impairments or who are ...
Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...
Magnesium has become one of the most popular supplements on the market. People take it for a whole host of reasons, ranging ...
Year-to-date as of June 30, 2026, Stone Sentinel Capital (“SSC”) gained 7.6% while the S&P 500 Total Return Index (“S&P TR”) ...
In New York, a property’s classification as “specialty” depends on its ongoing function, not just active use. Even if ...
Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results